Di-tert-butylphenyl phenyl phosphate

362.399741

438.19600

265-859-8

G6GJ3O93F3

DTXSID3028269

54.57000

7.92650

1.12g/cm3

482.9ºC at 760 mmHg

259ºC

1.548

Not Classified

A comatose patient who is diaphoretic, has pinpoint pupils and the odor of an insecticide on clothing or breath, and is noted to have muscle fasciculations represents the classic presentation of organophosphate poisoning. ... Specific steps in management include the following. 1. Decontamination. ... 2 Airway. Establish an airway if necessary. ... 3. Respiratory Status. Respiratory distress, in fact, is commonly found in these patients from multiple causes. ... 4. Cardiac Monitoring. ... 5. Cholinesterase Level. ... 6. Pralidoxime. Pralidoxime is the treatment of choice for organophosphate poisoning and should be used for nearly all patients with clinically significant orgnophosphate poisoning,particularly whose patients with muscular fasciculations and weakness. ... 7. Atropine. Atropine is the physiologic antidote for organophosphate poisoning. A trial dose of atropine should be instituted on clinical ground when one suspects organophosphate intoxication. /Organophosphate poisoning/

Organophosphorus cmpd can produce dermal irritation but most are weak sensitizers. /Organophosphate cmpd/

A common fire retardant plasticizer consisiting mainly of tert-butylphenyl diphenyl phosphate, di-tert-butylphenyl phenyl phosphate, and tri-phenyl phosphate.

Plastic material and resin manufacturing|Phosphoric acid, bis[(1,1-dimethylethyl)phenyl] phenyl ester: ACTIVE|TP - indicates a substance that is the subject of a proposed TSCA section 4 test rule.